What is the fair value of biote Corp (NASDAQ-BTMD) stock?

The current fair value estimate for biote Corp (NASDAQ-BTMD) is $3.38. This implies an estimated upside of 30.6% versus the current market price.

Is biote Corp (NASDAQ-BTMD) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 30.6% versus the current market price.

What is the analyst price target for NASDAQ-BTMD stock?

The available analyst price target for biote Corp (NASDAQ-BTMD) is $2.73. The analyst target implies estimated upside of 5.5%.

How is the financial health of biote Corp?

The current financial health read for biote Corp (NASDAQ-BTMD) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is biote Corp's next earnings date?

The next earnings date currently listed for biote Corp (NASDAQ-BTMD) is August 6, 2026.

Does biote Corp (NASDAQ-BTMD) pay dividends?

Based on the current data, dividend yield is 0.0%.

What is the P/E ratio for biote Corp (NASDAQ-BTMD)?

The current P/E ratio listed for biote Corp (NASDAQ-BTMD) is 5.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of biote Corp?

The current market capitalization listed for biote Corp is 88.527 M.

What is the enterprise value of biote Corp?

The current enterprise value listed for biote Corp is 190.1 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for biote Corp?

The ticker symbol for biote Corp is NASDAQ-BTMD, and the stock is listed on NASDAQ.

Where is biote Corp (NASDAQ-BTMD) listed?

biote Corp (NASDAQ-BTMD) is listed on NASDAQ.

What is the debt-to-total-capital ratio for biote Corp?

The current debt-to-total-capital ratio listed for biote Corp is 52.9%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for biote Corp?

The free float listed for biote Corp is 64.7%. Free float helps investors understand how much of the share base is available for public trading.

Biote Corp (BTMD) Fair Value & Stock Analysis

Biote Corp (BTMD)

biote Corp is a healthcare company listed on NASDAQ under the ticker BTMD. The company operates a practice-building business focused on hormone optimization, supporting physicians and nurse practitioners who use bioidentical hormone replacement pellet therapy for men and women experiencing hormonal imbalance. Its Biote Method platform provides certified practitioners with education, training, certification, practice management software, inventory tracking tools, product information, and digital and point-of-care marketing support. biote also sells dietary supplements under the Biote brand and sterile pellet insertion kits used in hormone optimization therapies. Founded in 2012, the company is headquartered in Irving, Texas.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Upcoming Dividend Ex-Date	Dividend Payment Date	Upcoming Dividend	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NASDAQ-BTMD	$3.38	30.6% Upside	Undervalued	$2.73	5.5% Upside	Fair	Great	—	—	—	0.0%	August 6, 2026	5.1x	-1.6x	0.5x	88.527 M	190.1 M	52.9%	64.7%	3.5	—	185.1%

Send a message